Prestige Consumer Healthcare Inc
NYSE:PBH
Prestige Consumer Healthcare Inc
NYSE:PBH
Price:
71.26 USD
0.2%
Updated:
May 3, 2024
EV/EBIT
Enterprise Value to EBIT
Enterprise Value to EBIT
-225.6
Current
12.5
Median
17
Industry
Lower
than median
Lower
than industry value
Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.
EV/EBIT
=-225.6
Enterprise Value
/
4.7B
EBIT
-20.7m
All Countries
| Market Cap | EV/EBIT | ||||
|---|---|---|---|---|---|
| US |
|
Prestige Consumer Healthcare Inc
NYSE:PBH
|
3.5B USD | -225.6 | |
| JP |
N
|
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
|
776 550.9T JPY | -5 046 864.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
717.6B USD | 71 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
3.7T DKK | 35.7 | |
| UK |
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 17 702.3 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
360.9B USD | 15.7 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
324.7B USD | 53.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
187.8B GBP | 225.8 | |
| CH |
|
Novartis AG
SIX:NOVN
|
181.2B CHF | 16.2 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
172.7B CHF | 10.2 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
156.4B USD | 16.3 |
EV/EBIT Forward Multiples
Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/EBIT
13.2
2-Years Forward
EV/EBIT
12.8
3-Years Forward
EV/EBIT
12.6
You don't have any saved screeners yet
